IP Advisories Resources for Patent: Pharmaceuticals & Biotechnology

Intellectual Property Advisory: Effective Timeline for the America Invents Act

Intellectual Property Advisory - Recent Bills (Re)Introduced in Congress Directed to Pharmaceutical Companies

Harold H. Fox, Timothy C. Bickham, and William Z. Nakhleh
March 30, 2009

Intellectual Property Advisory - FDA Denies 30-Month Stay of Approval of Certain ANDAs Under the QI-Act

Harold H. Fox, Timothy C. Bickham, and William Z. Nakhleh
March 23, 2009

Intellectual Property Advisory - Amendments to Chinese Patent Law Affecting Pharmaceutical and Biotech Companies

Harold H. Fox, Timothy C. Bickham, and William Z. Nakhleh
February 16, 2009

Intellectual Property Advisory - New Requirements for Submission of Bioequivalence Data for Generic Drug Applications

Harold H. Fox, Timothy C. Bickham, and William Z. Nakhleh
January 28, 2009